Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$6.92M Buy
51,215
+48,363
+1,696% +$5.97M 0.62% 48
2018
Q1
$378K Sell
2,852
-181
-6% -$24.3K 0.04% 246
2017
Q4
$450K Buy
3,033
+28
+0.9% +$3.81K 0.04% 226
2017
Q3
$395K Sell
3,005
-818
-21% -$110K 0.04% 236
2017
Q2
$508K Sell
3,823
-214
-5% -$28.9K 0.06% 214
2017
Q1
$543K Sell
4,037
-112
-3% -$14.5K 0.07% 215
2016
Q4
$496K Buy
+4,149
New +$489K 0.06% 215

Other funds holding CLX

Edge Advisors's CLX Position: Q2 2018 in Review

Edge Advisors increased its Clorox (CLX) stake by 1,696% in Q2 2018, buying an estimated $5.97M and bringing the position to 51,215 shares worth $6.92M. The position accounts for 0.62% of the portfolio, ranked #48.

Edge Advisors first reported a position in CLX in Q4 2016 and has held it in 7 quarters since. 917 funds tracked by Wall St. Rank hold CLX as of Q2 2018.

  • Edge Advisors held 51,215 shares of Clorox worth $6.92M as of Q2 2018.
  • Edge Advisors bought 48,363 Clorox shares in Q2 2018, an estimated $5.97M.
  • Clorox made up 0.62% of Edge Advisors's portfolio in Q2 2018, its #48 holding.
  • Edge Advisors first reported a position in Clorox in Q4 2016 and has held it in 7 quarters since.
  • 917 funds tracked by Wall St. Rank held Clorox as of Q2 2018.

Based on Edge Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.